Alternatives to Government-Imposed Price Controls to Lower US Drug Prices
This JAMA Forum discusses the limits of most-favored-nation pricing and other price controls on US drugs and provides policy alternatives, including generic and biosimilar competition, value-based pricing, and reforms to pharmacy benefit managers.
Authors
- Lanhee J. Chen
Institutions
- Hoover Institution (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.5744
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00